UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 281

Sortiert nach

Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis

Journal of internal medicine, 2021-06, Vol.289 (6), p.895-905

2021

Link zum Volltext

Verfügbarkeit prüfen

One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition

Journal of internal medicine, 2017-04, Vol.281 (4), p.337-347

2017

Link zum Volltext

Verfügbarkeit prüfen

Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis

The Journal of pathology, 2008-10, Vol.216 (2), p.253-261

2008

Link zum Volltext

Verfügbarkeit prüfen

Liver Transplantation for Familial Amyloidotic Polyneuropathy (FAP): A Single‐Center Experience Over 16 Years

American journal of transplantation, 2007-11, Vol.7 (11), p.2597-2604

2007

Link zum Volltext

Verfügbarkeit prüfen

Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy

Neurogastroenterology and motility, 2012-12, Vol.24 (12), p.1111-e568

2012

Link zum Volltext

Verfügbarkeit prüfen

Do troponin and B‐natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?

Journal of internal medicine, 2008-03, Vol.263 (3), p.294-301

2008

Link zum Volltext

Verfügbarkeit prüfen

Hereditary transthyretin amyloidosis from a Scandinavian perspective

Journal of internal medicine, 2003-09, Vol.254 (3), p.225-235

2003

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients

Clinical genetics, 2009-02, Vol.75 (2), p.163-168

2009

Link zum Volltext

Verfügbarkeit prüfen

Amyloid heart disease mimicking hypertrophic cardiomyopathy

Journal of internal medicine, 2005-09, Vol.258 (3), p.225-230

2005

Link zum Volltext

Verfügbarkeit prüfen

Impact of homozygosity for an amyloidogenic transthyretin mutation on phenotype and long term outcome

Journal of medical genetics, 2005-12, Vol.42 (12), p.953-956

2005

Link zum Volltext

Verfügbarkeit prüfen

On the Origin of the Transthyretin Val30Met Familial Amyloid Polyneuropathy

Annals of human genetics, 2008-07, Vol.72 (4), p.478-484

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 open-label extension study of patisiran, an investigational siRNA agent for hereditary ATTR amyloidosis with polyneuropathy (hATTR-PN)

Neuromuscular disorders : NMD, 2016, Vol.26, p.S142-S142

2016

Link zum Volltext

Verfügbarkeit prüfen

P72 Liver transplantation for familial amyloidosis; long-term data from the Familial Amyloid Polyneuropathy World Transplant Registry (FAPWTR)

Gut, 2011-09, Vol.60 (Suppl 2), p.A33-A34

2011

Link zum Volltext

Verfügbarkeit prüfen

P.024 Long-term use of patisiran in patients with hereditary transthyretin amyloidosis (hATTR): 12 month efficacy & safety data from a global open label extension (OLE) study

Canadian journal of neurological sciences, 2019-06, Vol.46 (s1), p.S20-S20

2019

Link zum Volltext

Verfügbarkeit prüfen

P.025 APOLLO, a phase 3 study of patisiran for the treatment of hereditary transthyretin amyloidosis (hATTR): 18-month safety and efficacy in subgroup with cardiac involvement

Canadian journal of neurological sciences, 2019-06, Vol.46 (s1), p.S20-S20

2019

Link zum Volltext

Verfügbarkeit prüfen

Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type

Transplantation, 2002-03, Vol.73 (5), p.745

2002

Link zum Volltext

Verfügbarkeit prüfen

Discordant penetrance of the trait for familial amyloidotic polyneuropathy in two pairs of monozygotic twins

Journal of internal medicine, 2004-11, Vol.256 (5), p.453-456

2004

Link zum Volltext

Verfügbarkeit prüfen

Over‐expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis

Clinical and experimental immunology, 2003-10, Vol.134 (1), p.127-137

2003

Link zum Volltext

Verfügbarkeit prüfen

Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial

Neurology, 2012-08, Vol.79 (8), p.785

2012

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of pre-transplant cardiomyopathy in Swedish liver transplanted patients for familial amyloidotic polyneuropathy

Amyloid, 2011-06, Vol.18 (Suppl. 1), p.171-173

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial: the safety and short‐term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn’s disease

Alimentary pharmacology & therapeutics, 2010-02, Vol.31 (3), p.387-395

2010

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of undiagnosed coeliac disease in adults: a Swedish population‐based study

Journal of internal medicine, 1999-01, Vol.245 (1), p.63-68

1999

Link zum Volltext

Verfügbarkeit prüfen

138. Tafamidis and nerve fiber function in transthyretin-type familial amyloid polyneuropathy

Clinical neurophysiology, 2012-06, Vol.123 (6), p.e56-e56

2012

Link zum Volltext

Verfügbarkeit prüfen

155. Nerve conduction in symptomatic patients in the transthyretin amyloidosis outcomes survey

Clinical neurophysiology, 2012-06, Vol.123 (6), p.e61-e61

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(238)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis

One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition

Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis

Liver Transplantation for Familial Amyloidotic Polyneuropathy (FAP): A Single‐Center Experience Over 16 Years

Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy

Do troponin and B‐natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?

Hereditary transthyretin amyloidosis from a Scandinavian perspective

Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients

Amyloid heart disease mimicking hypertrophic cardiomyopathy

Impact of homozygosity for an amyloidogenic transthyretin mutation on phenotype and long term outcome

On the Origin of the Transthyretin Val30Met Familial Amyloid Polyneuropathy

Phase 2 open-label extension study of patisiran, an investigational siRNA agent for hereditary ATTR amyloidosis with polyneuropathy (hATTR-PN)

P72 Liver transplantation for familial amyloidosis; long-term data from the Familial Amyloid Polyneuropathy World Transplant Registry (FAPWTR)

P.024 Long-term use of patisiran in patients with hereditary transthyretin amyloidosis (hATTR): 12 month efficacy & safety data from a global open label extension (OLE) study

P.025 APOLLO, a phase 3 study of patisiran for the treatment of hereditary transthyretin amyloidosis (hATTR): 18-month safety and efficacy in subgroup with cardiac involvement

Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type

Discordant penetrance of the trait for familial amyloidotic polyneuropathy in two pairs of monozygotic twins

Over‐expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis

Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial

Prognostic value of pre-transplant cardiomyopathy in Swedish liver transplanted patients for familial amyloidotic polyneuropathy

Clinical trial: the safety and short‐term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn’s disease

High prevalence of undiagnosed coeliac disease in adults: a Swedish population‐based study

Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?

138. Tafamidis and nerve fiber function in transthyretin-type familial amyloid polyneuropathy

155. Nerve conduction in symptomatic patients in the transthyretin amyloidosis outcomes survey

Suchergebnisse filtern